Topiramate, carbamazepine, and valproate monotherapy: Double-blind comparison in children with newly diagnosed epilepsy

Journal of Child Neurology

Volumn 19, Issue 2, 2004, Pages 135-141

  Wheless, James W ^a,c   Neto, Walter ^b   Wang, Steven ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c Texas Comprehensive Epilepsy Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ALOPECIA; ANOREXIA; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HUMAN; INCREASED APPETITE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEMORY DISORDER; MENTAL CONCENTRATION; MONOTHERAPY; MULTICENTER STUDY; NAUSEA AND VOMITING; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN;

EID: 12144287824     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190020901     Document Type: Article

References (24)

1. Elterman RD, Glauser TA, Wyllie E, et al: A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Neurology 1999;52:1338-1344.
2. Ritter F, Glauser TA, Elterman R, Wyllie E, and the Topiramate YP Study Group: Effectiveness, tolerability, and safety of topiramate in children with partial-onset seizures. Epilepsia 2000;41(Suppl 1):SS2-S85.
3. Biton V, Montouris GD, Ritter F, et al: A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Neurology 1999;52:1330-1337.
4. Montouris GD, Biton V, Rosenfeld WE, and the Topiramate YTC/YTCE Study Group: Nonfocal generalized tonic-clonic seizures: Response during long-term topiramate treatment. Epilepsia 2000;41(Suppl 1):S77-S81.
5. Biton V, Rosenfeld WE, Twyman R, Lim P: Topiramate (TPM) in juvenile myoclonic epilepsy (JME): Observations from randomized controlled trials in primary generalized tonic-clonic seizures (PGTCS). Epilepsia 1999;40(Suppl 7):218.
6. Rosenfeld WE, Schaefer PA, Lippmann SM: Topiramate in patients with juvenile myoclonic epilepsy. Epilepsia 1998;39(Suppl 6):139.
7. Sachdeo RC, Glauser TA, Ritter F, et al: A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Neurology 1999;52:1882-1887.
8. Glauser TA, Levisohn PM, Ritter F, Sachdeo RC, and the Topiramate YL Study Group: Topiramate in Lennox-Gastaut syndrome: Open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000;41(Suppl 1):S86-S90.
9. Guerreiro MM, Manreza MLG, Scotoni AE, et al: A pilot study of topiramate in children with Lennox-Gastaut syndrome. Arq Neurosiquiatr 1999;57(2-A):167-175.
10. Glauser TA, Clark PO, Strawsburg R: A pilot study of topiramate in the treatment of infantile spasms. Epilepsia 1998;39:1324-1328.
11. Glauser TA, Clark PO, McGee K: Long-term response to topiramate in patients with West syndrome. Epilepsia 2000;41(Suppl 1):S91-S94.
12. Cross JH: Topiramate monotherapy for childhood absence seizures: An open-label pilot study. Seizure 2002;11:406-410.
13. Gilliam FG, Reife R, Wu S-C: A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003;60:196-202.
14. Privitera MD, Brodie MJ, Mattson RH, et al, for the EPMN 105 Study Group: Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003;107:165-175.
15. Commission on Classification and Terminology, International League Against Epilepsy: Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
16. Wallace SJ: A comparative review of the adverse effects of anti-convulsants in children with epilepsy. Drug Saf 1996;15:378-393.
17. Arroyo S, Squires L, Wang S, Twyman R: Topiramate: Effective as monotherapy in dose-response study in newly diagnosed epilepsy. Epilepsia 2002;43(Suppl 7):241.
18. MacDonald BK, Johnson AL, Goodridge DM, et al: Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000;48:833-841.
19. Kwan P, Brodie MJ: Effectiveness of first antiepileptic drug. Epilepsia 2001;42:1255-1260.
20. Verity CM, Hosking G, Easter DJ, on behalf of The Paediatric EPITEG Collaborative Group: A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. Dev Med Child Neurol 1995;37:97-108.
21. de Silva M, MacArdle B, McGowan M, et al: Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-713.
22. Guerreiro MM, Vigonius U, Pohlmann H, et al: A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997; 27:205-213.
23. Canadian Study Group for Childhood Epilepsy: Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998;39:952-959.
24. Morita DA, Glauser TA, Hamant E, Guo SS: Effect of topiramate on linear growth in children with refractory complex partial seizures. Neurology 2000;54(Suppl 3):A193.